查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854707

工业微生物市场按产品类型、应用、最终用户、技术和微生物类型划分－2025-2032年全球预测

Industrial Microbiology Market by Product Type, Application, End User, Technology, Organism Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，工业微生物市场规模将达到 350.3 亿美元，年复合成长率为 8.36%。

关键市场统计数据
基准年 2024 184.1亿美元
预计年份：2025年 199.6亿美元
预测年份 2032 350.3亿美元
复合年增长率 (%) 8.36%

具有前瞻性的方向，阐述了工业微生物学如何整合技术创新、营运扩展和监管指导，从而实现跨行业的商业性化应用。

工业微生物学正迅速从一门专业科学学科发展成为永续製造、治疗创新和循环经济倡议的策略引擎。该领域正与先进的生物製程工程、计算菌株设计和新兴原料供应链相互融合，从而改变企业对生产风险、产品上市时间和成本结构的思考方式。投资者和技术领袖不仅关註生物系统的能力，也关注支撑这些能力的生态系统：可扩展的生物反应器、可重复的下游工作流程以及促进工业应用的监管途径。

本导言将读者置于科学与商业化的交会点。它确立了核心领域：包括高价值分子和生物基大宗材料在内的产品类别；涵盖农业到环境修復等应用领域的广泛应用；以及将运作或采购这些技术的机构使用者。此外，它还强调了建立健全的分析流程以及研发、监管和营运团队之间跨职能协作的必要性。透过阐明目前影响决策的因素，本部分旨在帮助领导者解读详细的分析结果，并优先考虑投资，从而在合理的时间范围内实现技术成熟和市场应用。

全面审视再形成工业微生物学并重新定义竞争和营运模式的重大技术、监管、金融和永续性驱动型变革。

工业微生物学领域正因技术、政策和市场预期三者交汇融合而发生变革，机会与风险也随之改变。合成生物学和自动化菌株工程的发展缩短了研发週期，降低了早期失败率；生物反应器控制和下游製程的改进提高了产量稳定性，并降低了规模化生产的变异性。同时，永续性发展的迫切需求和企业净零排放承诺正在再形成对生物基原料和循环生产方式的需求，促使各组织重新评估其材料采购和生命週期指标。

法律规范也在不断发展，监管机构正在明确基因改造生物、环境释放和产品标籤等方面的要求。这种监管势头可能会加速或阻碍商业化进程，这取决于其与合规路径的契合度以及公众的接受程度。投资者对平台技术和垂直整合营运模式的兴趣日益浓厚，这些模式将菌株开发与管理式生产相结合。最后，模组化、分散式生产系统的日益普及催生了新的经营模式，例如合约开发和生产、分散式微型工厂以及按产量付费的服务模式。

本报告对美国近期贸易行动至2025年期间将如何影响工业微生物学相关人员的生物製程投入、设备采购和战略采购选择进行了综合分析。

美国近期推出的关税措施和贸易政策调整将持续到2025年，这些措施增加了生技药品原料和设备供应链的成本和物流复​​杂性，并引发连锁反应，产业领导者必须对此有所预见。针对进口实验室设备、特殊化学品和某些发酵耗材的关税，如果国内没有其他供应商，可能会增加到岸投入成本并延误资本计划。这些变化将影响供应商合格认定，以及企业在多大程度上优先考虑在地采购、回流生产和策略性库存缓衝以保障关键营运。

关税导致的供应链重组不仅会直接影响成本，还会改变筹资策略和伙伴关係模式。依赖海外专用生物反应器组件或专有试剂的公司将面临更长的前置作业时间和潜在的单一来源风险，因此多供应商评估和供应商弹性计画的重要性日益凸显。另一方面，随着企业加快国内替代方案的认证，一些国内供应商和整合商的需求可能会增加。企业还必须考虑间接影响，例如关税合规行政负担加重、货运动态变化以及可能影响长期资本预算的政策波动。为了有效应对，企业需要将关税敏感性情境纳入其采购、风险管理和采购蓝图，同时持续关注影响全球贸易流动的政策发展和外交动态。

一种综合性的、以细分为主导的观点，将产品类型、应用领域、最终用户画像、技术模式和生物体类型联繫起来，从而确定开发路径和商业契合度的优先顺序。

从细分市场层面了解情况，可以发现技术发展在哪些方面满足了商业性需求，以及在哪些方面受到营运限制，阻碍了技术的应用。以产品为中心的细分涵盖胺基酸、抗生素、生质燃料、生质塑胶、酵素和维生素。酵素尤其值得关注，因为其在动物饲料、清洁剂和食品加工等目标市场中有着不同的下游商业化路径，而每个市场都有不同的配方和监管要求。应用细分涵盖农业、生质燃料、环境修復、食品饮料和製药。在製药领域，药物发现和配方的动态变化会影响研发进度和监管复杂性，进而导致不同的投资前景。

终端用户细分区分了农业公司、环境保护机构、食品製造商、製药公司和研究机构，这决定了采购速度、风险接受度以及对长期伙伴关係的期望。技术细分着重于生物反应器、细胞培养、下游加工和发酵，其中发酵进一步细分为固体发酵和液态发酵，二者在稳健性、资本密集度和原料灵活性方面存在差异。生物类型分为藻类、细菌、真菌和酵母，细菌进一步细分为革兰氏阴性菌和革兰氏阳性菌。整合这些细分层级可以突出哪些协同投资（例如，将液态发酵技术与用于特定酶产品的革兰氏阳性菌生产宿主相结合）能够加速商业化，以及哪些终端用户需求与技术成熟度之间的不匹配会造成摩擦，需要製定有针对性的开发和伙伴关係策略。

透过策略性区域评估，识别美洲、欧洲、中东和非洲以及亚太地区的创新丛集、製造业优势和政策环境，为全球扩张计画提供资讯。

地理动态持续影响技术能力、监管清晰度和资本汇聚的地点，从而形成创新和製造能力中心。在美洲，成熟的生物丛集支撑着从研发到製造的一体化价值链，并受益于深厚的创业投资网络和成熟的合约研发生产机构（CDMO）生态系统。欧洲、中东和非洲则呈现出异质性格局：欧洲部分地区拥有完善的监管环境，而其他地区则对新兴製造业的需求日益增长，永续性发展政策推动了对生质塑胶和可再生生物基解决方案的需求。

亚太地区的特点是产能快速扩张、公共和私人部门积极投资生物产业工业，以及上游原料生产商和下游加工商之间高度整合的供应链。区域专业化程度至关重要，有些地区优先发展药品和生技药品，而有些地区则专注于大宗生质燃料和工业酶，这影响企业如何伙伴关係、技术转移和监管协调。跨境因素，包括贸易协定、智慧财产权保护和区域标准的协调统一，持续影响企业研发中心和製造地的选址。因此，决策者必须评估区域优势，而不能孤立地看待，而应将其纳入多司法管辖区的策略考量，以优化客户接近性、供应链稳健性和监管协调性。

检验决定竞争优势的企业策略和经营能力，包括平台所有权、垂直整合、伙伴关係和人力资本实力。

公司层面的动态变化揭示了其竞争地位的形成，而这种竞争地位源自于技术平台、製造能力和商业通路的独特组合。一些公司专注于平台菌株的工程设计和许可，建立深厚的智慧财产权和模组化技术体系，从而实现快速客製化。另一些公司则透过将菌株开发与专有的发酵製程和下游纯化相结合，进行垂直整合，缩短获利路径。还有一部分公司作为灵活的服务提供者和契约製造，为没有内部设施的新兴开发商提供规模化生产和生产能力。在这些模式下取得成功的公司展现出严谨的计划执行能力、完善的品质体系，以及将实验室可重复性与稳定的工业生产结合的能力。

与原料供应商、法规顾问和承购客户建立跨产业伙伴关係的公司可以降低早期商业营运风险并加速产品推广。与设备供应商和自动化厂商建立策略联盟可以进一步提升营运绩效。此外，对数位化过程控制和分析的投资能够区分那些能够稳定扩展规模、但又难以应对波动性的企业。最后，人力资本，例如经验丰富的发酵科学家、法规事务专家和营运经理，仍然是关键的差异化因素，能够帮助公司执行复杂的计划并快速应对技术或法规方面的挑战。

为领导者提供以行动为导向的建议，以加强供应链、提升製造灵活性、整合监管前瞻性并协调商业性伙伴关係，从而实现快速规模化发展。

产业领导者必须优先考虑兼顾创新和营运韧性的实际行动。首先，加强供应商多元化和资格确认通讯协定，减少关键设备、试剂和耗材的单一来源采购。其次，投资模组化、灵活的生产设施，以实现产品快速切换，并相容于液态和固体发酵方法，从而优化不同产品类型和终端市场的材料利用率和製程经济性。

企业还需要在研发专案早期阶段就纳入监管讯息，以使菌株工程和製程设计与可预测的合规路径保持一致，并缩短药品、食品应用和环境排放核准的时间。研发、营运和商业部门之间的跨职能整合能够加强优先排序，并确保技术里程碑反映买方检验的规范。领导者应寻求策略伙伴关係关係，以确保承购和原材料协议，并探索与本地製造合作伙伴的共同投资安排，以降低资本密集度并加快市场进入。最后，对员工进行生物製程自动化、品质系统和数据分析的培训，将使企业能够维持可重复的生产和持续改进。

一份透明的调查方法概述，其中描述了主要访谈、次要技术分析、细分市场划分和情境测试。

本分析的调查方法结合了定性和定量方法，以确保技术可信度和商业性相关性。主要研究包括对行业高管、技术领导者、采购专家和监管顾问进行结构化访谈，以获取关于营运限制、策略重点和新兴机会的第一手观点。次要研究则检验了同行评审文献、专利概况、监管指导文件和公司披露信息，以验证技术声明并追踪不同生物物种和工艺模式下的技术成熟度路径。

分析方法包括交叉细分映射，以确定产品类型与特定技术栈和最终用户需求的匹配程度；情境分析，以检验采购和营运假设对政策和贸易发展的敏感度；以及能力比较评估，以衡量公司层面的优势。在整个过程中，研究结果透过多方资讯来源进行三角验证，以减少偏差，并突出共识观点和关键分歧。这种调查方法既能得出可靠的结论，又能根据具体的组织环境和策略问题进行细緻入微的解读。

简明扼要的总结强调，工业微生物学的创新需要整合营运、监管和商业能力，才能实现持续的市场影响。

工业微生物学正日趋成熟，成为一个策略性领域，技术创新必须与务实的营运设计和监管前瞻性相结合，才能实现商业性目标。那些将平台级菌株工程与灵活的生产策略和多元化的采购管道结合的企业，将更有能力应对政策变化和供应链中断。基于细分市场的策略将有助于找到针对特定产品类型和终端市场的最佳发展路径。

负责人应抓住机会，透过增加对流程分析、人才培育和合作伙伴生态系统的投资，将自身的技术能力转化为具有韧性的经营模式。这样做有助于降低执行风险，在以伙伴关係永续性的市场中获得先发优势，并使其能够灵活应对不断变化的法规和贸易环境。商业性成功将取决于开发、製造、采购和市场推广等各环节的整合能力。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 推出人工智慧驱动的生物製程优化平台，以提高微生物发酵的产量
  • 扩大精准发酵技术规模，实现乳製品和肉蛋白的永续生产
  • 利用 CRISPR-Cas9 基因编辑技术加速特种化学品的生物合成
  • 开发一种基于微生物群落的生物反应器，用于高效处理工业污水
  • 利用基因优化的PHA累积微生物扩大生物基塑胶的生产规模
  • 将即时微生物生物感测器整合到生物製造过程中以进行品管

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的工业微生物市场

  • 胺基酸
  • 抗生素
  • 生质燃料
  • 生质塑胶
  • 酵素
    • 动物饲料
    • 清洁剂
    • 食品加工
  • 维他命

9. 按应用分類的工业微生物市场

  • 农业
  • 生质燃料
  • 环境
  • 食品/饮料
  • 製药
    • 药物发现
    • 开处方药

10. 按最终用户分類的工业微生物市场

  • 农业企业
  • 环境机构
  • 食品製造商
  • 製药公司
  • 研究所

11. 按技术分類的工业微生物市场

  • 生物反应器
  • 细胞培养
  • 下游加工
  • 发酵
    • 固体发酵
    • 深层发酵

12. 依微生物类型分類的工业微生物市场

  • 藻类
  • 细菌
    • 革兰氏阴性菌
    • 革兰氏阳性菌
  • 真菌
  • 酵母菌

13. 各地区工业微生物市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 工业微生物市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国工业微生物市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Novozymes A/S
    • Koninklijke DSM NV
    • DuPont de Nemours, Inc.
    • BASF SE
    • Evonik Industries AG
    • Chr. Hansen Holding A/S
    • Ajinomoto Co., Inc.
    • Kerry Group plc
    • Lonza Group AG
    • Archer Daniels Midland Company
Product Code: MRR-957C47F92627

The Industrial Microbiology Market is projected to grow by USD 35.03 billion at a CAGR of 8.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.41 billion
Estimated Year [2025] USD 19.96 billion
Forecast Year [2032] USD 35.03 billion
CAGR (%) 8.36%

A forward-looking orientation describing how industrial microbiology integrates technical innovation, operational scaling, and regulatory navigation to enable commercial adoption across industries

Industrial microbiology is rapidly evolving from a specialized scientific discipline into a strategic engine for sustainable manufacturing, therapeutic innovation, and circular economy initiatives. The field now intersects advanced bioprocess engineering, computational strain design, and emergent feedstock supply chains in ways that change how companies conceive of production risk, time to market, and cost structures. Investors and technology leaders are focusing not only on the capabilities of biological systems but on the ecosystem that enables them: scalable bioreactors, reproducible downstream workflows, and regulatory pathways that permit industrial adoption.

This introduction situates the reader at the nexus of science and commercialization. It establishes the core domains-product classes that include high-value molecules and bulk bio-based materials, application areas from agriculture to environmental remediation, and the institutional users who operate or procure these technologies. It emphasizes the imperative for robust analytical pipelines and cross-functional collaboration between R&D, regulatory, and operations teams. By clarifying the drivers that currently shape decision-making, this section prepares leaders to interpret detailed analyses and to prioritize investments that deliver technical maturity and market relevance within realistic timelines.

A synthesis of the key technological, regulatory, financial, and sustainability-driven changes reshaping industrial microbiology and redefining competitive and operational models

The landscape of industrial microbiology is being transformed by converging shifts in technology, policy, and market expectations that alter both opportunity and execution risk. Advances in synthetic biology and automated strain engineering have shortened development cycles and reduced failure rates at early stages, while improvements in bioreactor control and downstream processing have increased yield consistency and reduced variability at scale. At the same time, sustainability imperatives and corporate net-zero commitments are reshaping demand toward bio-based inputs and circular manufacturing approaches, pushing organizations to re-evaluate feedstock sourcing and life-cycle metrics.

Regulatory frameworks are also evolving, with authorities clarifying requirements for genetically modified organisms, environmental releases, and product labeling. This regulatory momentum accelerates or constrains commercialization depending on alignment with compliance pathways and with public acceptance. Financing patterns are shifting as well: investors demonstrate growing interest in platform technologies and vertically integrated plays that combine strain development with manufacturing control. Finally, the increased availability of modular and distributed production systems is enabling new business models, including contract development and manufacturing, decentralized microfactories, and pay-per-output service arrangements, which collectively alter how companies scale and compete.

An integrated analysis of how recent United States trade measures through 2025 affect bioprocess inputs, equipment procurement, and strategic sourcing choices for industrial microbiology stakeholders

Recent tariff actions and trade policy adjustments in the United States through 2025 have introduced additional layers of cost and logistical complexity across biologics inputs and equipment supply chains, with ripple effects that industry leaders must anticipate. Tariffs that target imported laboratory equipment, specialty chemicals, or certain fermentation consumables elevate landed input costs and can delay capital projects when alternative suppliers are not available domestically. These shifts influence supplier qualification decisions and the degree to which organizations prioritize local sourcing, onshoring, or strategic inventory buffering to protect critical operations.

Beyond immediate cost implications, tariff-driven supply chain realignments change procurement strategies and partnership models. Entities reliant on specialized foreign bioreactor components or proprietary reagents face longer lead times and potential single-source risks, which increases the value of multi-sourcing assessments and vendor resiliency planning. Conversely, some domestic suppliers and integrators may see expanded demand as firms accelerate qualification of local alternatives. Firms must also weigh the indirect impacts: increased administrative burden for customs compliance, shifting freight dynamics, and the potential for policy volatility that complicates long-term capital budgeting. To respond effectively, organizations should integrate tariff sensitivity scenarios into sourcing, risk management, and procurement roadmaps while continuing to monitor policy developments and diplomatic shifts that affect global trade flows.

A comprehensive segmentation-driven perspective linking product categories, application domains, end-user profiles, technology modalities, and organism types to prioritize development pathways and commercial fit

Segment-level understanding reveals where technical development aligns with commercial demand and where operational constraints constrain adoption. Product-focused segmentation spans amino acids, antibiotics, biofuels, bioplastics, enzymes, and vitamins; within this frame, enzymes warrant special attention because their downstream commercialization paths differ depending on target markets such as animal feed, detergents, and food processing, each with distinct formulation and regulatory requirements. Application segmentation covers agriculture, biofuels, environmental remediation, food and beverage, and pharmaceuticals, and within pharmaceuticals the dynamics of drug discovery versus drug formulation influence timelines and regulatory complexity, creating divergent investment profiles.

End-user segmentation differentiates agriculture firms, environmental agencies, food manufacturers, pharmaceutical companies, and research institutes, which in turn determine procurement cadence, risk tolerance, and long-term partnership expectations. Technology segmentation emphasizes bioreactors, cell culture, downstream processing, and fermentation, where fermentation further divides into solid state and submerged approaches that vary by robustness, capital intensity, and feedstock flexibility. Organism type segmentation distinguishes algae, bacteria, fungi, and yeast, and the bacterial category subdivides into Gram-negative and Gram-positive strains, which carry different genetic toolkits and containment considerations. Synthesizing these segmentation layers clarifies where synergistic investments-such as pairing submerged fermentation expertise with Gram-positive production hosts for specific enzyme outputs-deliver accelerated commercialization, and where mismatches between end-user needs and technological maturity create friction that demands targeted development or partnership strategies.

A strategic regional appraisal identifying innovation clusters, manufacturing strengths, and policy environments across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform global deployment plans

Geographic dynamics continue to influence where technological capability, regulatory clarity, and capital converge to create hubs of innovation and manufacturing capacity. In the Americas, established industrial biotech clusters support integrated development-to-manufacturing value chains, strengthened by deep venture capital networks and mature CDMO ecosystems; this region often leads in translational platforms that bridge discovery and scale-up. Europe, Middle East & Africa exhibits a heterogeneous landscape where regulatory sophistication in parts of Europe coexists with emerging manufacturing ambitions elsewhere, and where sustainability-oriented policy initiatives drive demand for bioplastics and renewable bio-based solutions.

Asia-Pacific is characterized by rapid capacity expansion, aggressive public and private investment in bioindustrial parks, and strong supply-chain integration with upstream feedstock producers and downstream processors. Regional specialization matters: certain countries within each region prioritize pharmaceuticals and biologics, while others focus on bulk biofuels or enzymes for industrial use, influencing how companies approach partnerships, technology transfer, and regulatory alignment. Cross-border considerations, such as trade agreements, intellectual property protection, and regional standards harmonization, continue to shape where companies establish R&D centers and manufacturing footprints. Decision-makers must therefore assess regional advantages not only in isolation but as part of a multi-jurisdictional strategy that optimizes proximity to customers, robustness of supply chains, and regulatory alignment.

An examination of corporate strategies and operational capabilities that determine competitive advantage including platform ownership, vertical integration, partnerships, and human capital strengths

Company-level dynamics reveal competitive positioning that stems from unique combinations of technological platforms, manufacturing capability, and commercial channels. Some firms concentrate on platform strain engineering and licensing, building deep IP estates and modular technology suites designed for rapid customization, while others vertically integrate to combine strain development with proprietary fermentation processes and downstream purification that shorten paths to revenue. A third cohort operates as flexible service providers and contract manufacturers, offering scale-up and production capacity to emerging developers who lack in-house facilities. Across these models, successful companies demonstrate disciplined project execution, robust quality systems, and the ability to translate laboratory reproducibility into consistent industrial output.

Collaborative behavior also differentiates leaders: those that form cross-sector partnerships with feedstock suppliers, regulatory consultants, and offtake customers can de-risk early commercial runs and accelerate adoption. Strategic alliances with equipment suppliers and automation vendors further strengthen operational performance. Additionally, investments in digital process control and analytics separate organizations that can reliably scale from those that struggle with variability. Finally, human capital-experienced fermentation scientists, regulatory affairs professionals, and operations managers-remains a critical differentiator, enabling firms to execute complex projects and to respond rapidly to technical or regulatory challenges.

Action-oriented recommendations for leaders to fortify supply chains, modernize manufacturing flexibility, integrate regulatory foresight, and align commercial partnerships for rapid scale-up

Industry leaders must prioritize pragmatic actions that balance innovation with operational resilience. First, strengthen supplier diversification and qualification protocols to reduce single-source exposure for critical equipment, reagents, and consumables; this reduces vulnerability to trade disruptions and supports predictable scale-up timelines. Next, invest in modular and flexible manufacturing assets that enable rapid product changeover and that accommodate both submerged and solid state fermentation modalities to optimize feedstock use and process economics across product types and end markets.

Firms should also embed regulatory intelligence early in development programs, aligning strain engineering and process design with foreseeable compliance pathways to reduce time-to-approval friction for pharmaceuticals, food applications, and environmental releases. Cross-functional integration between R&D, operations, and commercial functions will enhance prioritization and ensure that technical milestones translate into buyer-validated specifications. Leaders should pursue strategic partnerships that secure offtake or feedstock contracts, and they should explore co-investment arrangements with local manufacturing partners to mitigate capital intensity and to accelerate market entry. Finally, cultivating workforce skills in bioprocess automation, quality systems, and data analytics will ensure that organizations can sustain reproducible manufacturing and continuous improvement.

A transparent methodological overview describing primary interviews, secondary technical analysis, segmentation mapping, and scenario testing used to produce defensible and actionable conclusions

The research methodology underpinning this analysis combined qualitative and quantitative approaches designed to ensure technical credibility and commercial relevance. Primary research included structured interviews with industry executives, technical leaders, procurement specialists, and regulatory advisors to capture firsthand perspectives on operational constraints, strategic priorities, and emergent opportunities. Secondary research synthesized peer-reviewed literature, patent landscapes, regulatory guidance documents, and company disclosures to validate technical claims and to trace technology maturation paths across organism types and process modalities.

Analytical techniques included cross-segmentation mapping to identify where product types align with specific technology stacks and end-user requirements, scenario analysis to test the sensitivity of sourcing and operational assumptions to policy and trade developments, and comparative capability assessments to benchmark firm-level strengths. Throughout the process, findings were triangulated across multiple sources to reduce bias and to highlight both consensus views and material disagreements. This methodology supports robust conclusions while allowing for nuanced interpretation tailored to specific organizational contexts and strategic questions.

A concise synthesis reinforcing that technical innovation in industrial microbiology requires integrated operational, regulatory, and commercial capabilities to realize durable market impact

The conclusion synthesizes the report's central insights: industrial microbiology is maturing into a strategic domain where technical innovation must be matched by pragmatic operational design and regulatory foresight to achieve commercial outcomes. Organizations that pair platform-level strain engineering with flexible manufacturing strategies and diversified sourcing are best positioned to navigate policy shifts and supply-chain disruptions. Regional differences will continue to influence where firms prioritize capital deployment, while segmentation-informed strategies illuminate the most viable paths for specific product types and end markets.

Leaders should treat the current moment as an opportunity to translate technological capability into resilient business models by accelerating investments in process analytics, workforce development, and partnership ecosystems. By doing so, they can reduce execution risk, capture early adopter advantages in sustainability-oriented markets, and position their organizations to respond nimbly to evolving regulatory and trade conditions. The cumulative message is clear: technical excellence alone is necessary but insufficient; commercial success depends on integrated capability across development, manufacturing, procurement, and market engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven bioprocess optimization platforms to enhance microbial fermentation yields
  • 5.2. Expansion of precision fermentation techniques for sustainable dairy and meat protein production
  • 5.3. Implementation of CRISPR-Cas9 strain engineering to accelerate specialty chemical biosynthesis
  • 5.4. Development of microbial consortia-based bioreactors for efficient industrial wastewater treatment
  • 5.5. Scale-up of bio-based plastic production using genetically optimized PHA-accumulating microorganisms
  • 5.6. Integration of real-time microbial biosensors into biomanufacturing processes for quality control

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Industrial Microbiology Market, by Product Type

  • 8.1. Amino Acids
  • 8.2. Antibiotics
  • 8.3. Biofuels
  • 8.4. Bioplastics
  • 8.5. Enzymes
    • 8.5.1. Animal Feed
    • 8.5.2. Detergents
    • 8.5.3. Food Processing
  • 8.6. Vitamins

9. Industrial Microbiology Market, by Application

  • 9.1. Agriculture
  • 9.2. Biofuels
  • 9.3. Environmental
  • 9.4. Food And Beverage
  • 9.5. Pharmaceuticals
    • 9.5.1. Drug Discovery
    • 9.5.2. Drug Formulation

10. Industrial Microbiology Market, by End User

  • 10.1. Agriculture Firms
  • 10.2. Environmental Agencies
  • 10.3. Food Manufacturers
  • 10.4. Pharmaceutical Companies
  • 10.5. Research Institutes

11. Industrial Microbiology Market, by Technology

  • 11.1. Bioreactor
  • 11.2. Cell Culture
  • 11.3. Downstream Processing
  • 11.4. Fermentation
    • 11.4.1. Solid State Fermentation
    • 11.4.2. Submerged Fermentation

12. Industrial Microbiology Market, by Organism Type

  • 12.1. Algae
  • 12.2. Bacteria
    • 12.2.1. Gram Negative
    • 12.2.2. Gram Positive
  • 12.3. Fungi
  • 12.4. Yeast

13. Industrial Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Industrial Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Industrial Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Novozymes A/S
    • 16.3.2. Koninklijke DSM N.V.
    • 16.3.3. DuPont de Nemours, Inc.
    • 16.3.4. BASF SE
    • 16.3.5. Evonik Industries AG
    • 16.3.6. Chr. Hansen Holding A/S
    • 16.3.7. Ajinomoto Co., Inc.
    • 16.3.8. Kerry Group plc
    • 16.3.9. Lonza Group AG
    • 16.3.10. Archer Daniels Midland Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INDUSTRIAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INDUSTRIAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INDUSTRIAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AMINO ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY VITAMINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DRUG FORMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY AGRICULTURE FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BIOREACTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SOLID STATE FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBMERGED FERMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ALGAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FUNGI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY YEAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY FERMENTATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ORGANISM TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY BACTERIA, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE INDUSTRIAL MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE INDUSTRI